
Hee-yong Kim
Examiner (ID: 10576, Phone: (571)270-3669 , Office: P/2482 )
| Most Active Art Unit | 2482 |
| Art Unit(s) | 2621, 2482 |
| Total Applications | 605 |
| Issued Applications | 466 |
| Pending Applications | 1 |
| Abandoned Applications | 142 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17850509
[patent_doc_number] => 20220280550
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/745464
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745464
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745464 | Hydroxypropyl beta-cyclodextrin compositions and methods | May 15, 2022 | Issued |
Array
(
[id] => 17850510
[patent_doc_number] => 20220280551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => HYDROXYPROPYL BETA-CYCLODEXTRIN COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/745487
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43846
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17745487
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/745487 | Hydroxypropyl beta-cyclodextrin compositions and methods | May 15, 2022 | Issued |
Array
(
[id] => 20577277
[patent_doc_number] => 12569512
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-03-10
[patent_title] => Heparan sulfate (HS) oligosaccharides effect in liver ischemia reperfusion injury
[patent_app_type] => utility
[patent_app_number] => 17/744407
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 43
[patent_no_of_words] => 8524
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744407
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744407 | Heparan sulfate (HS) oligosaccharides effect in liver ischemia reperfusion injury | May 12, 2022 | Issued |
Array
(
[id] => 17836380
[patent_doc_number] => 20220273685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PULSATILLA CHINENSIS EXTRACT IN PREPARING DRUG FOR TREATING VIRAL AND/OR BACTERIAL DISEASES
[patent_app_type] => utility
[patent_app_number] => 17/662725
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662725
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/662725 | Uses of Pulsatilla Chinensis extract in preparing drug for treating viral and/or bacterial diseases | May 9, 2022 | Issued |
Array
(
[id] => 19418442
[patent_doc_number] => 20240294565
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => UNNATURAL CONFIGURATION NUCLEOTIDE PRODRUG COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/561681
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11347
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18561681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/561681 | UNNATURAL CONFIGURATION NUCLEOTIDE PRODRUG COMPOUNDS | May 9, 2022 | Pending |
Array
(
[id] => 17944415
[patent_doc_number] => 20220331432
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => PROCESSES FOR PRODUCING PHARMACEUTICAL EXCIPIENTS FROM LIGNOCELLULOSIC BIOMASS, AND PHARMACEUTICAL EXCIPIENTS OBTAINED THEREFROM
[patent_app_type] => utility
[patent_app_number] => 17/739376
[patent_app_country] => US
[patent_app_date] => 2022-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12852
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739376
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/739376 | PROCESSES FOR PRODUCING PHARMACEUTICAL EXCIPIENTS FROM LIGNOCELLULOSIC BIOMASS, AND PHARMACEUTICAL EXCIPIENTS OBTAINED THEREFROM | May 8, 2022 | Abandoned |
Array
(
[id] => 18383344
[patent_doc_number] => 11654108
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-05-23
[patent_title] => Sennoside medicated chews
[patent_app_type] => utility
[patent_app_number] => 17/734794
[patent_app_country] => US
[patent_app_date] => 2022-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6602
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17734794
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/734794 | Sennoside medicated chews | May 1, 2022 | Issued |
Array
(
[id] => 18747071
[patent_doc_number] => 11806362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-07
[patent_title] => Heparin and heparan sulphate oligosaccharides
[patent_app_type] => utility
[patent_app_number] => 17/728503
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 68
[patent_no_of_words] => 21568
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728503
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728503 | Heparin and heparan sulphate oligosaccharides | Apr 24, 2022 | Issued |
Array
(
[id] => 18057962
[patent_doc_number] => 20220389048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => PROCESS FOR PREPARING 3'-O-AMINO-RIBONUCLEOTIDE
[patent_app_type] => utility
[patent_app_number] => 17/726745
[patent_app_country] => US
[patent_app_date] => 2022-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6756
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17726745
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/726745 | PROCESS FOR PREPARING 3'-O-AMINO-RIBONUCLEOTIDE | Apr 21, 2022 | Abandoned |
Array
(
[id] => 19297562
[patent_doc_number] => 20240226127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-11
[patent_title] => NUCLEOSIDE COMPOUND AND APPLICATION THEREOF IN THE TREATMENT OF FELINE INFECTIOUS PERITONITIS
[patent_app_type] => utility
[patent_app_number] => 18/287722
[patent_app_country] => US
[patent_app_date] => 2022-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5428
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287722
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287722 | NUCLEOSIDE COMPOUND AND APPLICATION THEREOF IN THE TREATMENT OF FELINE INFECTIOUS PERITONITIS | Apr 20, 2022 | Pending |
Array
(
[id] => 19247594
[patent_doc_number] => 20240198579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => CELLULOSE-BASED FILAMENTS, FILMS AND 3D OBJECTS AND METHODS OF MANUFACTURE THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/555768
[patent_app_country] => US
[patent_app_date] => 2022-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21659
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18555768
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/555768 | CELLULOSE-BASED FILAMENTS, FILMS AND 3D OBJECTS AND METHODS OF MANUFACTURE THEREOF | Apr 19, 2022 | Pending |
Array
(
[id] => 19263601
[patent_doc_number] => 20240207298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => NUTRITIONAL SUPPLEMENTS FOR AMELIORATION OF RESPIRATORY TRACT INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/287376
[patent_app_country] => US
[patent_app_date] => 2022-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -62
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18287376
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/287376 | NUTRITIONAL SUPPLEMENTS FOR AMELIORATION OF RESPIRATORY TRACT INFECTIONS | Apr 18, 2022 | Pending |
Array
(
[id] => 17792042
[patent_doc_number] => 20220251133
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => METHOD OF MAKING NICOTINAMIDE RIBOFURANOSIDE SALTS, NICOTINAMIDE RIBOFURANOSIDE SALTS AS SUCH, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/711799
[patent_app_country] => US
[patent_app_date] => 2022-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18134
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711799
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/711799 | Method of making nicotinamide ribofuranoside salts, nicotinamide ribofuranoside salts as such, and uses thereof | Mar 31, 2022 | Issued |
Array
(
[id] => 18792659
[patent_doc_number] => 11826392
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-11-28
[patent_title] => Purification method of fungal cell wall composition
[patent_app_type] => utility
[patent_app_number] => 17/657021
[patent_app_country] => US
[patent_app_date] => 2022-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2754
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 152
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17657021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/657021 | Purification method of fungal cell wall composition | Mar 28, 2022 | Issued |
Array
(
[id] => 18003610
[patent_doc_number] => 20220362376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-17
[patent_title] => ADJUVANT AND VACCINE COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/656750
[patent_app_country] => US
[patent_app_date] => 2022-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20045
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17656750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/656750 | ADJUVANT AND VACCINE COMPOSITIONS | Mar 27, 2022 | Abandoned |
Array
(
[id] => 19217899
[patent_doc_number] => 20240182603
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => SULFUR-SUBSTITUTED SUGAR TO STABILIZE OLIGOSACCHARIDE
[patent_app_type] => utility
[patent_app_number] => 18/551000
[patent_app_country] => US
[patent_app_date] => 2022-03-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551000
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/551000 | SULFUR-SUBSTITUTED SUGAR TO STABILIZE OLIGOSACCHARIDE | Mar 17, 2022 | Pending |
Array
(
[id] => 17734688
[patent_doc_number] => 20220220147
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => CD73 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/697318
[patent_app_country] => US
[patent_app_date] => 2022-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64119
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -110
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17697318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/697318 | CD73 inhibitors | Mar 16, 2022 | Issued |
Array
(
[id] => 18643280
[patent_doc_number] => 11767340
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-09-26
[patent_title] => Crystalline forms of LNT
[patent_app_type] => utility
[patent_app_number] => 17/653819
[patent_app_country] => US
[patent_app_date] => 2022-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4790
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17653819
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/653819 | Crystalline forms of LNT | Mar 6, 2022 | Issued |
Array
(
[id] => 20264186
[patent_doc_number] => 12435162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-07
[patent_title] => Preparation method for acetylated sodium hyaluronate
[patent_app_type] => utility
[patent_app_number] => 17/918906
[patent_app_country] => US
[patent_app_date] => 2022-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 0
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17918906
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/918906 | Preparation method for acetylated sodium hyaluronate | Feb 27, 2022 | Issued |
Array
(
[id] => 19140487
[patent_doc_number] => 20240139276
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-05-02
[patent_title] => HAIR GROWTH AGENT
[patent_app_type] => utility
[patent_app_number] => 18/278728
[patent_app_country] => US
[patent_app_date] => 2022-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18278728
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/278728 | HAIR GROWTH AGENT | Feb 24, 2022 | Pending |